Old drug, new data

Advances in Psychiatric Treatment

Volumn 12, Issue 4, 2006, Pages 256-264

  Ferrier, I Nicol ^a,b,c,d   Ferrie, Lindsey J ^a   Macritchie, Karine A ^e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45249125262     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.12.4.256     Document Type: Article

References (63)

1. Adityanjee, Munshi, K. R. & Thampy, A. (2005) The syndrome of irreversible lithium-effectuated neurotoxicity. Clinical Neuropsychopharmacology, 28, 38-49.
2. Ahluwalia, P. & Singhal, R. L. (1981) Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal. Neuropsychopharmacology, 20, 483-487.
3. Ahrens, B. & Muller-Oerlinghausen, B. (2001) Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry, 34, 132-136.
4. Antonelli, T., Ferioli, V., Lo Gallo, G., et al (2000) Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat. Synapse, 38, 355-362.
5. Bauer, M. & Döpfmer, S. (1999) Lithium augmentation in treatment-resistant depression: a meta-analysis of placebo-controlled studies. Journal of Clinical Psychopharmacology, 19, 427-434.
6. Bendz, A. & Aurell, M. (1999) Drug-induced diabetes insipidus: incidence, prevention and management. Drug Safety, 21, 449-456.
7. Berggren, U. (1985) Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine induced locomotor stimulation in rats. Journal of Neural Transmission, 64, 239-250.
8. Berk, M., Ichim, M. & Brook, S. (1999) Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Internal Clinical Psychopharmacology, 14, 339-343.
9. Bowden, C. L., Brugger, A. M., Swann, A. C., et al (1994) Efficacy of Divalproex vs lithium and placebo in the treatment of mania. JAMA, 271, 918-924.
10. Bowen, R. C., Grof, P. & Grof, E. (1991) Less frequent lithium administration and lower urine volume. American Journal of Psychiatry, 148, 189-192.
11. Burgess, S., Geddes, J., Hawton, K., et al (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews, issue 3. Oxford: Update Software. DOI: 10.1002/ 14651858.CD003013.
12. Bymaster, F. P. & Felder, C. C. (2002) Role of cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Molecular Psychiatry, 7 (suppl. 1), S57-S63.
13. Chen, G., Masana, M. I. & Manji, H. K. (2000) Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Bipolar Disorder, 2, 217-236.
14. Chuang, D. M. (2004) Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Critical Reviews in Neurobiology, 16, 83-90.
15. Chuang, D. M., Chen, R. W., Chalecka-Franaszek, E., et al (2002) Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disorder, 4, 129-136.
16. Cipriani, A., Wilder, H., Hawton, K., et al (2005) Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomised trials. American Journal of Psychiatry, 162, 1805-1819.
17. Coryell, W., Solomon, D., Leon, A. C., et al (1998) Lithium discontinuation and subsequent effectiveness. American Journal of Psychiatry, 155, 895-898.
18. De Bruin, V. M. S., Marinho, M. M. F., De Sousa, F. C. F., et al (2000) Behavioural and neurochemical alterations after lithium-pilocarpine administration in young and adult rats. A comparative study. Pharmacology Biochemistry and Behavior, 65, 547-551.
19. Dziedzicka-Wasylewska, M., Mackowiak, M., Fijar, K., et al (1996) Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. Journal of Neural Transmission, 103, 765-776.
20. Faedda, G. L., Tondo, L., Baldessarinini, R. J., et al (1993) Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Archives of General Psychiatry, 50, 448-455.
21. Ferrie, L., Young, A. H. & McQuade, R. (2005) Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. Journal of Psychopharmacology, 19, 229-234.
22. Ferrier, I. N., Tyrer, S. P. & Bell, A. J. (1995) Lithium therapy. Advances in Psychiatric Treatment, 1, 102-108.
23. Geddes, J. R. (2004) Bipolar disorder. American Family Physician: Clinical Evidence Concise, 69, 1721-1722. http://www.aafp.org/afp/20040401/bmjx.html
24. Goldberg, H., Clayman, P. & Skorecki, K. (1988) Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells. American Journal of Physiology, 255, F995-1002.
25. Goodwin, F. K., Fireman, B., Simon, G. E., et al (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290, 1467-1473.
26. Goodwin, G. (1994) Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry, 164, 149-152.
27. Goodwin, G. M., Bowden, C. L., Calabrese, J. R., et al (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. Journal of Clinical Psychiatry, 65, 432-441.
28. Gurvich, N. & Klein, P. S. (2002) Lithium and valproic acid: parallels and contrasts in diverse signalling contexts. Pharmacology and Therapeutics, 96, 45-66.
29. Hallcher, L. M. & Sherman, W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry, 255, 10896-10901.
30. Hansen, H. E., Hesbech, J., Sorensen, J. L., et al (1979) Chronic interstitial nephropathy in patients on long-term lithium treatment. Quarterly Journal of Medicine, 48, 577-591.
31. Hestbech, J., Hansen, H. E., Amdisen, A., et al (1977) Chronic renal lesions following long-term treatment with lithium. Kidney International, 12, 205-213.
32. Ichim, L., Berk, M. & Brook, S. (2000) Lamotrigine compared with lithium in mania: a double blind randomized controlled trial. Annals of Clinical Psychiatry, 12, 5-10.
33. Jope, R. S. (1993) Lithium selectively potentiates cholinergic activity in rat brain. Progress in Brain Research, 98, 317-322.
34. Kameda, K., Miura, J., Suzuki, K., et al (2001) Effects of lithium on dopamine D2 receptor expression in the rat brain striatum. Journal of Neural Transmission, 108, 321-334.
35. Lang, E. J. & Davis, S. M. (2002) Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. Journal of Clinical Neuroscience, 9, 308-309.
36. Lenox, R. H. & Hahn, C. G. (2000) Overview of the mechanism of action of lithium in the brain. Fifty-year update. Journal of Clinical Psychiatry, 61 (suppl. 9), 5-15.
37. Lenox, R. H. & Manji, H. K. (1995) Lithium. In American Psychiatric Association Textbook of Psychopharmacology (eds A. F. Schatzberg & C. B. Nemeroff), pp. 303-349. Washington, DC: American Psychiatric Press.
38. Leucht, S., McGrath, J. & Kissling, W. (2004) Lithium for schizophrenia. Cochrane Library, issue 4. Oxford: Oxford Update Software.
39. Mai, L., Jope, R. S. & Li, X. (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. Journal of Neurochemistry, 82, 75-83.
40. Mander, A. J. & Loudon, J. B. (1988) Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet, 2, 15-17.
41. Manji, H. K. & Chen, G. (2002) PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilisers. Molecular Psychiatry, 7 (suppl. 1), S46-S56.
42. Manji, H. K. & Lenox, R. H. (1999) Ziskind-Somerfeld Research Award. Protein kinase C signalling in the brain: molecular transduction of mood stabilization in the treatment of manic- depressive illness. Biological Psychiatry, 46, 1328-1351.
43. Markowitz, G. S., Radhakrishnan, J., Kambham, N., et al (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology, 11, 1439-1448.
44. McCreadie, R. G., McCormick, M. & Morrison, D. P. (1985) The impact of lithium in South-West Scotland. III. The discontinuation of lithium. British Journal of Psychiatry, 146, 77-80.
45. Moore, G. J., Bebchuk, J. M., Hasanat, K., et al (2000) Lithium increases N-acetyl aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biological Psychiatry, 48, 1-8.
46. Motohashi, N. (1992) GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Progress in Neuropsychopharmacology and Biological Psychiatry, 16, 571-579.
47. Muller-Oerlinghausen, B., Felber W., Berghofer, A., et al (2005) The impact of lithium long-term medication on suicidal behaviour and mortality of bipolar patients. Archives of Suicide Research, 9, 307-319.
48. Nemeroff, C. B., Evans, D. L., Gyulai, L., et al (2001) Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry, 158, 906-912.
49. Nolen, W. A. & Bloemkolk D (2000) Treatment of bipolar depression: a review of the literature and a suggestion for an algorithm. Neuropsychobiology, 42 (suppl. 1), 11-17.
50. Perlis, R. H., Sachs, G. S., Lafer, B., et al (2002) Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. American Journal of Psychiatry, 159, 1155-1159.
51. Posner, L. & Mokrzycki, M. H. (1996) Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use. American Journal of Nephrology, 16, 339-343.
52. Price, L. H., Charney, D. S., Delgado, P. L., et al (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100, 3-12.
53. Ryves, W. J. & Harwood, A. J. (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochemical and Biophysical Research Communications, 280, 720-725.
54. Santella, R. N., Rimmer, J. M. & MacPherson, B. R. (1988) Focal segmental glomerulosclerosis in patients receiving lithium carbonate. American Journal of Medicine, 84, 951-954.
55. Shiah, I.-S. & Yatham, L. N. (2000) Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar Disorder, 2, 77-92.
56. Suppes, T., Baldessarini, R. J., Faedda, G. L., et al (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry, 48, 1082-1088.
57. Thies-Flechtner, K., Muller-Oerlinghausen, B., Seibert, W., et al (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry, 29, 103-107.
58. Thompson, J. M., Gallagher, P., Hughes, J. H., et al (2005) Neurocognitive impairment in euthymic patients with bipolar affective disorder. British Journal of Psychiatry, 186, 32-40.
59. Tohen, M., Greil, W., Calabrese, J. R., et al (2005) Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month randomized double-blind controlled clinical trial. American Journal of Psychiatry, 162, 1281-1290.
60. Tondo, L., Hennen, J., Baldessarini, R. J., et al (2001) Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatrica Scandinavica, 104, 163-172.
61. Wang, H., Lu, X. Q. & Zhang, Y. F. (1997) Modulation of phosphatidylinositol turnover on central nicotinic receptors. Zhongguo Yao Li Xue Bao, 18, 341-344.
62. Wang, H. Y., Johnson, G. P. & Friedman, E. (2001) Lithium treatment inhibits protein kinase C translocation in rat brain cortex. Psychopharmacology, 159, 80-86.
63. Wood, A. J. & Goodwin, G. M. (1987) A review of the biochemical and neuropharmacological actions of lithium. Psychological Medicine, 17, 579-600.